Shenzhen Hepalink Pharmaceutical Group Co Ltd - ESG Rating & Company Profile powered by AI
If you are employed by Shenzhen Hepalink Pharmaceutical Group Co Ltd and you wish to use your ESG rating, please contact us. Complete Sustainability analysis of Shenzhen Hepalink Pharmaceutical Group Co Ltd are accessed by signing up for free. Browse to the end of the webpage for potential risks for Shenzhen Hepalink Pharmaceutical Group Co Ltd based on sector, geography and marketcap.
Shenzhen Hepalink Pharmaceutical Group Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 5.3, social score of 4.6 and governance score of 6.7.
5.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
602 | SkinBioTherapeutics PLC | 5.6 | High |
602 | XOMA Corp | 5.6 | High |
627 | Shenzhen Hepalink Pharmaceutical Group Co Ltd | 5.5 | High |
627 | Advanced Medical Solutions Group PLC | 5.5 | High |
627 | Achieve Life Sciences Inc | 5.5 | High |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Shenzhen Hepalink Pharmaceutical Group Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd report the average age of the workforce?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd offer flexible work?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd conduct supply chain audits?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose water use targets?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Shenzhen Hepalink Pharmaceutical Group Co Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Shenzhen Hepalink Pharmaceutical Group Co Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Shenzhen Hepalink Pharmaceutical Group Co Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose its waste policy?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose energy use targets?
Sign up for free to unlockDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Shenzhen Hepalink Pharmaceutical Group Co Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Shenzhen Hepalink Pharmaceutical Group Co Ltd
These potential risks are based on the size, segment and geographies of the company.
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in Hong Kong, the United States, Europe, Mainland China, and internationally. The company operates through three segments: Finished Dose Pharmaceutical Products, Active Pharmaceutical Ingredients (API), and CDMO. Its pharmaceutical products consist of finished dose pharmaceutical products, which primarily include enoxaparin sodium injection; API products, including heparin sodium API and enoxaparin sodium API; and other products, including pancreatin API. The company is also involved in the provision of research and development, manufacturing, quality management, and program management services; and development and manufacture of recombinant pharmaceutical products, critical non-viral vectors, intermediates for gene therapy, and naturally derived pharmaceutical products. In addition, it engages in property management, investment management and consulting, biopharmaceutical technology development and consulting, and equity and venture investment activities; research, development, and production of biopharmaceuticals; and trading of medical products. The company was formerly known as Shenzhen Hepalink Pharmaceutical Co.,Ltd. and changed its name to Shenzhen Hepalink Pharmaceutical Group Co., Ltd. in February 2017. Shenzhen Hepalink Pharmaceutical Group Co., Ltd. was founded in 1998 and is headquartered in Shenzhen, China.